
Psychiatr Serv 52:619-625, May 2001
© 2001 American Psychiatric Association
Evidence-Based Pharmacologic Treatment for People With Severe Mental Illness:A Focus on Guidelines and Algorithms
Thomas A. Mellman, M.D.,
Alexander L. Miller, M.D.,
Ellen M. Weissman, M.D.,
M. Lynn Crismon, Pharm.D.,
Susan M. Essock, Ph.D. and
Stephen R. Marder, M.D.
Medication treatment of severe mental illness has been advanced and complicated by the introduction of numerous therapeutic agents. Practice guidelines based on research evidence have been developed to help clinicians make complex decisions. Studies of usual care suggest an important potential role for guidelines in improving the quality of medication treatment for people with severe mental illness. The authors review current evidence-based guidelines for medication treatment of persons with severe mental illness. Four categories of guidelines are described: recommendations, comprehensive treatment options, medication algorithms, and expert consensus. The authors note that more research is needed on optimal next-step strategies and the treatment of patients with comorbidity and other complicating problems. They discuss barriers to the implementation of guidelines, and they observe that the potential of guidelines and algorithms to promote evidence-based medication treatment for persons with severe mental illness depends on refinement of tools, progress in research, and cooperation of physicians, nonphysician clinicians, administrators, and consumers and family members.
This article has been cited by other articles:

|
 |

|
 |
 
P. E. Deegan and R. E. Drake
Shared Decision Making and Medication Management in the Recovery Process
Psychiatr Serv,
November 1, 2006;
57(11):
1636 - 1639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Salzman
The Limited Role of Expert Guidelines in Teaching Psychopharmacology
Acad Psychiatry,
June 1, 2005;
29(2):
176 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Conley, D. L. Kelly, T. J. Lambert, and R. C. Love
Comparison of Clozapine Use in Maryland and in Victoria, Australia
Psychiatr Serv,
March 1, 2005;
56(3):
320 - 323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Bond, H.-W. Kim, P. S. Meyer, P. J. Gibson, S. Tunis, J. D. Evans, P. Lysaker, M. L. McCoy, J. Dincin, and H. Xie
Response to Vocational Rehabilitation During Treatment With First- or Second-Generation Antipsychotics
Psychiatr Serv,
January 1, 2004;
55(1):
59 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Sohler, J. Walkup, D. McAlpine, C. Boyer, and M. Olfson
Antipsychotic Dosage at Hospital Discharge and Outcomes Among Persons With Schizophrenia
Psychiatr Serv,
September 1, 2003;
54(9):
1258 - 1263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Corrigan, L. Steiner, S. G. McCracken, B. Blaser, and M. Barr
Strategies for Disseminating Evidence-Based Practices to Staff Who Treat People With Serious Mental Illness
Psychiatr Serv,
December 1, 2001;
52(12):
1598 - 1606.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Frese III, J. Stanley, K. Kress, and S. Vogel-Scibilia
Integrating Evidence-Based Practices and the Recovery Model
Psychiatr Serv,
November 1, 2001;
52(11):
1462 - 1468.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2001
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|